Pages that link to "Q36189988"
Jump to navigation
Jump to search
The following pages link to Mild cognitive impairment as a clinical entity and treatment target (Q36189988):
Displaying 50 items.
- Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials (Q21092367) (← links)
- Contributions of neuropsychology and neuroimaging to understanding clinical subtypes of mild cognitive impairment (Q24629087) (← links)
- Posterior cingulum white matter disruption and its associations with verbal memory and stroke risk in mild cognitive impairment (Q24630245) (← links)
- Exercise-Related Changes of Networks in Aging and Mild Cognitive Impairment Brain (Q26751170) (← links)
- Working memory and executive function decline across normal aging, mild cognitive impairment, and Alzheimer's disease (Q26778406) (← links)
- Preclinical Alzheimer disease: identification of cases at risk among cognitively intact older individuals (Q26995405) (← links)
- A novel biomarker of amnestic MCI based on dynamic cross-frequency coupling patterns during cognitive brain responses. (Q27313916) (← links)
- (Q28081075) (← links)
- Connectivity Disruption, Atrophy, and Hypometabolism within Posterior Cingulate Networks in Alzheimer's Disease (Q28146452) (← links)
- Semicarbazide-sensitive amine oxidase (SSAO) and its possible contribution to vascular damage in Alzheimer's disease (Q28568746) (← links)
- Defining “Prodromal” Alzheimer’s Disease, Frontotemporal Dementia, and Lewy Body Dementia: Are we there yet? (Q28972451) (← links)
- Roles of 3-nitrotyrosine- and 4-hydroxynonenal-modified brain proteins in the progression and pathogenesis of Alzheimer's disease (Q30394816) (← links)
- Brain structural, functional, and cognitive correlates of recent versus remote autobiographical memories in amnestic Mild Cognitive Impairment (Q30408767) (← links)
- Naturalistic assessment of everyday functioning in individuals with mild cognitive impairment: the day-out task (Q30532472) (← links)
- Can multi-modal neuroimaging evidence from hippocampus provide biomarkers for the progression of amnestic mild cognitive impairment? (Q30884744) (← links)
- Use of functional magnetic resonance imaging in the early identification of Alzheimer's disease (Q31111440) (← links)
- Staging neurodegenerative disorders: structural, regional, biomarker, and functional progressions (Q33556006) (← links)
- Cognitive intervention in Alzheimer disease. (Q33661365) (← links)
- Potential biomarkers relating pathological proteins, neuroinflammatory factors and free radicals in PD patients with cognitive impairment: a cross-sectional study (Q33672820) (← links)
- Memantine and acetylcholinesterase inhibitor treatment in cases of CDR 0.5 or questionable impairment (Q33684234) (← links)
- Mild cognitive impairment: a concept and diagnostic entity in need of input from neuropsychology. (Q33688684) (← links)
- Detection of visuoperceptual deficits in preclinical and mild Alzheimer's disease. (Q33711721) (← links)
- Efficacy and Safety of an Herbal Therapy in Patients with Amnestic Mild Cognitive Impairment: A 24-Week Randomized Phase III Trial (Q33741404) (← links)
- Reframing person-centered nursing care for persons with dementia. (Q33748686) (← links)
- Trajectories of dementia-related cognitive decline in a large mental health records derived patient cohort (Q33773036) (← links)
- Brain substrates of learning and retention in mild cognitive impairment diagnosis and progression to Alzheimer's disease (Q33776799) (← links)
- Changes in mobility among older adults with psychometrically defined mild cognitive impairment (Q33785213) (← links)
- NOX activity is increased in mild cognitive impairment (Q33830110) (← links)
- Profile of hippocampal volumes and stroke risk varies by neuropsychological definition of mild cognitive impairment (Q33830534) (← links)
- Neuropsychological contributions to the early identification of Alzheimer's disease (Q33899973) (← links)
- Complex activities of daily living vary by mild cognitive impairment subtype (Q33936555) (← links)
- Lower hippocampal volume predicts decrements in lane control among drivers with amnestic mild cognitive impairment (Q33966405) (← links)
- Performance-based measures of everyday function in mild cognitive impairment (Q33978664) (← links)
- Everyday episodic memory in amnestic mild cognitive impairment: a preliminary investigation (Q33982038) (← links)
- Lack of association between 11C-PiB and longitudinal brain atrophy in non-demented older individuals (Q34012320) (← links)
- Differences in brain volume, hippocampal volume, cerebrovascular risk factors, and apolipoprotein E4 among mild cognitive impairment subtypes (Q34019150) (← links)
- The spectrum of cognitive impairment in Lewy body diseases (Q34019751) (← links)
- Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates (Q34047002) (← links)
- Cognitive correlates of functional abilities in individuals with mild cognitive impairment: comparison of questionnaire, direct observation, and performance-based measures (Q34051487) (← links)
- Social relationships and risk of incident mild cognitive impairment in U.S. Alzheimer's disease centers (Q34071138) (← links)
- Automated assessment of cognitive health using smart home technologies (Q34083729) (← links)
- Naturalistic assessment of everyday activities and prompting technologies in mild cognitive impairment (Q34087538) (← links)
- Subtypes of mild cognitive impairment in older postmenopausal women: the Women's Health Initiative Memory Study (Q34088579) (← links)
- Stroke risk modifies regional white matter differences in mild cognitive impairment (Q34160849) (← links)
- Prevalence, distribution, and impact of mild cognitive impairment in Latin America, China, and India: a 10/66 population-based study (Q34162212) (← links)
- Factors associated with primary care physicians' recognition of cognitive impairment in their older patients (Q34175651) (← links)
- Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease (Q34183061) (← links)
- Subjective cognitive complaints contribute to misdiagnosis of mild cognitive impairment (Q34231888) (← links)
- Accelerated progression from mild cognitive impairment to dementia in people with diabetes (Q34237746) (← links)
- Mild cognitive impairment: statistical models of transition using longitudinal clinical data (Q34247588) (← links)